EPA approves honeybee miticide for all 50 states
"Canada’s regulatory agency granted full approval to Apivar in July 2012, so, now that the U.S. is on board, we are very enthusiastic about the impact that Apivar can have on the health of the North American honeybee population," Nobre said. "Early indications tell us the product is being warmly welcomed in the U.S. market, and we look forward to moving Apivar into the Mexican market in the very near future."
Véto-pharma S.A. is a veterinary pharmaceutical company that develops and markets innovative products to help commercial and hobbyist beekeepers prevent and control hive diseases and improve honeybee health. Véto-pharma's products are sold to beekeepers through distributors in North America, Europe and Asia. Headquartered in Paris, the Company's U.S. operations are based in New York, NY. Visit www.apivar.net for more information.
- Deere to lay off more than 600 at four U.S. plants
- Slow pace of rail recovery stirs fear of future woes
- The four pillars of seeing opportunities in problems
- WinField introduces Answer Tech and Data Silo
- Ohio’s largest Deere dealer to sell precision drone products
- New DuPont Afforia herbicide introduced for soybeans
- No El Niño in 2014? Drought-weary California in trouble
- Suspected Bt corn rootworm resistance in Pennsylvania
- BioNitrogen to build second fertilizer plant in Texas
- Commentary: Setting the record straight on 'Waters of the U.S.'
- Soybean aphid numbers on the rise
- Solar energy jobs increase, wind power decrease